Pancreatic Cancer Research

ResearcherHeidelberg UniversityActive in the last 2 years

Martin A. Schneider

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8215-7359; OpenAlex author ID A5041117409. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 3 papers · 2021: 5 papers · 2022: 4 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 14

  1. Preoperative Surgical or Endoscopic Bile Duct Drainage in Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000006407↗
  2. [Locally advanced pancreatic cancer after FOLFIRINOX: surgical resection enhances survival]. Co-author DOI 10.1007/s00104-021-01558-8↗
  3. Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve. Co-author DOI 10.1097/sla.0000000000004054↗
  4. Actual Five-year Survival After Upfront Resection for Pancreatic Ductal Adenocarcinoma: Who Beats the Odds? Co-author DOI 10.1097/sla.0000000000004147↗
  5. Resection of Recurrent Pancreatic Cancer: Who Can Benefit? Last author DOI 10.1159/000519754↗
  6. [Neoadjuvant treatment of locally advanced pancreatic cancer: outcomes after complete response]. Co-author DOI 10.1007/s00104-021-01492-9↗
  7. Periarterial divestment in pancreatic cancer surgery. Co-author DOI 10.1016/j.surg.2020.08.030↗
  8. Technical advances in surgery for pancreatic cancer. Co-author DOI 10.1093/bjs/znab133↗
  9. Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-21-0353↗
  10. Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk. Co-author DOI 10.3389/fgene.2021.693933↗
  11. Cavernous transformation of the portal vein in pancreatic cancer surgery-venous bypass graft first. Co-author DOI 10.1007/s00423-020-01974-0↗
  12. Commentary: Neoadjuvant treatment of resectable pancreatic cancer: Lack of level III evidence. Co-author DOI 10.1016/j.surg.2020.07.033↗
  13. Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes. Co-author DOI 10.1038/s41598-020-62416-x↗
  14. Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer. Co-author DOI 10.18632/oncotarget.2651↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Markus Wolfgang Büchler · 10 shared papers, 2020–2026 · strength 1.97
  2. Thilo Hackert · 7 shared papers, 2020–2026 · strength 1.03
  3. Oliver Strobel · 6 shared papers, 2020–2026 · strength 0.91
  4. Martin Loos · 3 shared papers, 2021–2026 · strength 0.49
  5. Markus K. Diener · 4 shared papers, 2020–2022 · strength 0.48
  6. Thomas Schmidt · 4 shared papers, 2014–2021 · strength 0.37
  7. Thomas P. Hank · 2 shared papers, 2022–2026 · strength 0.37
  8. Mohammed Al‐Saeedi · 2 shared papers, 2022–2026 · strength 0.37
  9. André L. Mihaljević · 3 shared papers, 2020–2022 · strength 0.36
  10. John P. Neoptolemos · 2 shared papers, 2020–2021 · strength 0.30
  11. Henrik Nienhüser · 1 shared paper, 2022 · strength 0.26
  12. Frank Pianka · 1 shared paper, 2026 · strength 0.24
  13. Rosa Klotz · 1 shared paper, 2026 · strength 0.24
  14. Benedict Kinny‐Köster · 1 shared paper, 2026 · strength 0.24
  15. Ulla Klaiber · 1 shared paper, 2022 · strength 0.13
  16. Dirk Jäger · 1 shared paper, 2022 · strength 0.12
  17. Willem Niesen · 1 shared paper, 2022 · strength 0.12
  18. Anna‐Katharina König · 1 shared paper, 2022 · strength 0.12
  19. Matthias M. Gaida · 1 shared paper, 2022 · strength 0.12
  20. Christoph Springfeld · 1 shared paper, 2022 · strength 0.12
  21. Jörg Kaiser · 1 shared paper, 2022 · strength 0.12
  22. Yi Miao · 1 shared paper, 2021 · strength 0.11
  23. Kuirong Jiang · 1 shared paper, 2021 · strength 0.11
  24. Thomas Moritz Pausch · 1 shared paper, 2020 · strength 0.11
  25. Massimiliano Mazzone · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.